Dermatan Sulfate Is Involved in the Tumorigenic Properties of Esophagus Squamous Cell Carcinoma

Department of Experimental Medical Science, Biomedical Center D12, Lund University, Lund, Sweden.
Cancer Research (Impact Factor: 9.28). 02/2012; 72(8):1943-52. DOI: 10.1158/0008-5472.CAN-11-1351
Source: PubMed

ABSTRACT Extracellular matrix, either produced by cancer cells or by cancer-associated fibroblasts, influences angiogenesis, invasion, and metastasis. Chondroitin/dermatan sulfate (CS/DS) proteoglycans, which occur both in the matrix and at the cell surface, play important roles in these processes. The unique feature that distinguishes DS from CS is the presence of iduronic acid (IdoA) in DS. Here, we report that CS/DS is increased five-fold in human biopsies of esophagus squamous cell carcinoma (ESCC), an aggressive tumor with poor prognosis, as compared with normal tissue. The main IdoA-producing enzyme, DS epimerase 1 (DS-epi1), together with the 6-O- and 4-O-sulfotransferases, were highly upregulated in ESCC biopsies. Importantly, CS/DS structure in patient tumors was significantly altered compared with normal tissue, as determined by sensitive mass spectrometry. To further understand the roles of IdoA in tumor development, DS-epi1 expression, and consequently IdoA content, was downregulated in ESCC cells. IdoA-deficient cells exhibited decreased migration and invasion capabilities in vitro, which was associated with reduced cellular binding of hepatocyte growth factor, inhibition of pERK-1/2 signaling, and deregulated actin cytoskeleton dynamics and focal adhesion formation. Our findings show that IdoA in DS influences tumorigenesis by affecting cancer cell behavior. Therefore, downregulation of IdoA by DS-epi1 inhibitors may represent a new anticancer therapy.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Glycosaminoglycans (GAGs) are found in intracellular granules, cell surfaces and extracellular matrices in a spatially and temporally regulated fashion, constituting the environment for cells to interact, migrate and proliferate. Through binding with a great number of proteins, GAGs regulate many facets of biological processes from embryonic development to normal physiological functions. GAGs have been shown to be involved in pathologic changes and immunological responses including cancer metastasis and inflammation. Past analyses of GAGs have focused on cell lines, body fluids and relatively large tissue samples. Structures determined from such samples reflect the heterogeneity of the cell types present. In order to gain an understanding of the roles played by GAG expression during pathogenesis, it is very important to be able to detect and profile GAGs at the histological scale so as to minimize cell heterogeneity to potentially inform diagnosis and prognosis. Heparan sulfate (HS) belongs to one major class of GAGs, characterized by dramatic structural heterogeneity and complexity. In order to demonstrate feasibility of analysis of HS, 13 µm frozen bovine brain stem, cortex and cerebellum tissue sections were washed with a series of solvent solutions to remove lipids before applying heparin lyases I, II, and III on the tissue surfaces within 5mm*5mm digestion spots. The digested HS disaccharides were extracted from tissue surfaces and then analyzed by using size exclusion chromatography/mass spectrometry (SEC-MS). The results from bovine brain stem, cortex and cerebellum demonstrated the reproducibility and reliability of our profiling method. We applied our method to detect HS from human astrocytoma (WHO grade II) and glioblastoma (GBM, WHO grade IV) frozen slides. Higher HS abundances and lower average sulfation level of HS were detected in glioblastomas (GBM, WHO grade IV) slides compared to astrocytoma WHO grade II slides.
    Analytical Chemistry 10/2013; 85(22). DOI:10.1021/ac402517s · 5.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Studies aimed at the identification of biomarkers and treatment targets of cancer have focused on mRNAs, miRNAs, and proteins expressed by malignant cells, while glycoproteins mainly produced by stromal cells remain relatively unexplored. Glycans lack a given template for their biosynthesis that involves the concerted action of several, sometimes >15 different enzymes. This fact complicates the analysis at the genomic level of the role of glycoproteins in clinical oncology. The glycosaminoglycans (GAGs) stand out as highly polyanionic components at the surface of malignant and stromal tumor cells as well as their surrounding matrix. Published data thus describe a multifaceted regulatory role of GAGs and GAG-conjugated proteins, proteoglycans, in e.g. tumor associated angiogenesis, coagulation, invasion, and metastasis. Relatively small, randomized clinical trials suggest that heparin, an over-sulfated variant of the GAG heparan sulfate, may have direct, anti-tumor effects. Several ongoing trials aim at establishing whether heparin and its derivatives should be added to standard treatment of cancer patients or not, based on progression free- and overall survival end-point data. Given the potential bleeding complications with this treatment, other strategies to block GAG function should provide interesting alternatives. In the emerging era of personalized medicine, one can foresee the development of predictive biomarkers to select patients that may benefit from GAG-targeted treatments, aiming at individualized prevention of thromboembolic complications as well as inhibition of tumor development and progression. Here, the role of GAGs as targets and vehicles of cancer treatment is discussed with special emphasis on angiogenesis and coagulation associated mechanisms. © 2014 Elsevier Ltd. All rights reserved.
    Thrombosis Research 05/2014; 133 Suppl 2:S95-S101. DOI:10.1016/S0049-3848(14)50016-3 · 2.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fibroblast growth factor-2 (Ffg2) is involved in several biological functions. Fgf2 requires glycosaminoglycans, like chondroitin/dermatan sulfate (CS/DS) as co-receptors. CS/DS are linear polysaccharides composed of repeating disaccharide units [-4GlcUAβ1-3-GalNAc-β1-] and [-4IdoUAα1-3-GalNAc-β1-], which can be sulfated. Uronyl 2-O-sulfotransferase (Ust) introduces sulfation at the C2 of IdoUA and GlcUA resulting in over-sulfated units. CHO-K1 cells over-expressing Ust contain significantly more CS/DS 2-O sulfated units, while Ust knock-down abolished CS/DS 2-O sulfation. Structural difference of CS/DS resulted in altered Fgf2 binding and increased p-ERK1/2. As functional consequence of CS/DS 2-O sulfation and altered Fgf2 binding, cell migration and paxillin activation was increased. Inhibition of sulfation, knock-down of Ust and inhibition of FgfR resulted in reduced migration. Similarly, Fgf2 treatment increased migration, which was abolished by Ust knock-down in 3T3 cells. The proteoglycan controlling the CHO migration was syndecan1. Knock-down of Sdc1 in CHO-K1/Ust abolished cell migration. We conclude that the presence of distinctly sulfated CS/DS can tune the Fgf2 effect on cell migration.
    Journal of Cell Science 12/2014; DOI:10.1242/jcs.152660 · 5.33 Impact Factor


Available from
May 31, 2014